http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101712409-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 |
| filingDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101712409-B1 |
| titleOfInvention | Esterified Aster glehni fraction as inhibitor of HMG-CoA reductase |
| abstract | (AGEM) obtained by ester chemical reaction of an ethyl acetate solvent fraction (AGE) of a scabbard, or an island obtained by fractionating the scabbard ester residue (AGEM) by concentration gradient column chromatography (AGEM-M) as an active ingredient, it is preferable that the fraction (AGEM) or the fraction (AGEM-M) of the scarab lily extract (AGEM-M) has excellent inhibitory activity against HMG-CoA reductase And to a pharmaceutical composition or a health food composition used for the purpose of lowering the concentration of blood cholesterol. |
| priorityDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.